Kemwell Biopharma Acquires Cirrus Pharmaceuticals Inc.
Kemwell Biopharma announced that it has acquired Cirrus Pharmaceuticals Inc., a contract development services company based in Research Triangle Park, N.C.
Kemwell Biopharma, a global bio/pharmaceutical contract services company headquartered in Bangalore, India, announced that it has acquired Cirrus Pharmaceuticals Inc., a contract development services company based in Research Triangle Park, N.C., USA.
Since its inception in 1997, Cirrus has developed expertise in inhalation, parenteral, transdermal, topical and liquid dosage forms. It also offers stand-alone analytical services including stability studies.
Kemwell’s corporate objective is to build a leading global bio/pharmaceutical contract services company, said Anurag Bagaria, chairman and MD of Kemwell in a press statement. Cirrus will complement the existing contract services offered by Kemwell with early stage innovative product development. Kemwell will now provide customers with a complete solution from early development in the US to commercial manufacturing in Kemwell’s EMA, FDA, and PMDA approved facilities in India and Sweden.”
Source: Kemwell Biopharma
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
